Severe relapse of epilepsy after vigabatrin withdrawal: for how long should we treat symptomatic infantile spasms?

Kröll-Seger, Judith; Kaminska, Anna; Moutard, Marie Laure; de Saint-Martin, Anne; Guët, Agnes; Dulac, Olivier; Chiron, Catherine

Kröll-Seger, Judith; Kaminska, Anna; Moutard, Marie Laure; de Saint-Martin, Anne; Guët, Agnes; Dulac, Olivier; Chiron, Catherine.

Epilepsia ; 48(3): 612-3, 2007 Mar.

Article in En | MEDLINE | ID: mdl-17346254

Subject(s)

Spasms, Infantile/chemically induced; Spasms, Infantile/drug therapy; Substance Withdrawal Syndrome/etiology; Vigabatrin/adverse effects; Cerebral Cortex/abnormalities; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infant; Infant, Newborn; Recurrence; Risk Assessment; Severity of Illness Index; Spasms, Infantile/diagnosis; Time Factors; Vigabatrin/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Spasms, Infantile / Substance Withdrawal Syndrome / Vigabatrin Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Child, preschool / Humans / Infant / Newborn Language: En Journal: Epilepsia Year: 2007 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links